| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sphingolipid delta-4 desaturase activity | 1.67e-05 | 2 | 82 | 2 | GO:0042284 | |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 4.98e-05 | 3 | 82 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 4.98e-05 | 3 | 82 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 9.94e-05 | 4 | 82 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.36e-04 | 120 | 82 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.74e-04 | 200 | 82 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.82e-04 | 27 | 82 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.04e-04 | 32 | 82 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | peptidase activity | PAPPA2 NLN XPNPEP3 GZMK RHBDL3 ADAMTS16 ADAM29 USP9Y ADAM12 CTSK | 3.39e-04 | 654 | 82 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 3.45e-04 | 7 | 82 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 3.45e-04 | 7 | 82 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.84e-04 | 430 | 82 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 8.94e-04 | 11 | 82 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 8.94e-04 | 11 | 82 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 1.26e-03 | 13 | 82 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 1.26e-03 | 13 | 82 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 1.26e-03 | 13 | 82 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.47e-03 | 14 | 82 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | clathrin binding | 2.22e-03 | 63 | 82 | 3 | GO:0030276 | |
| GeneOntologyCellularComponent | cilium | FSIP2 PDE4C GRK2 GRK3 HDAC6 CLCN4 DYNC2I2 PTPRK RDH11 GLI2 CFAP61 ADGRV1 BRWD1 | 5.77e-05 | 898 | 84 | 13 | GO:0005929 |
| Domain | DES1/DES2 | 2.05e-05 | 2 | 85 | 2 | IPR011388 | |
| Domain | DUF3657 | 2.05e-05 | 2 | 85 | 2 | IPR022122 | |
| Domain | Lipid_DES | 2.05e-05 | 2 | 85 | 2 | PF08557 | |
| Domain | DUF676 | 2.05e-05 | 2 | 85 | 2 | PF05057 | |
| Domain | Sphingolipid_d4-desaturase_N | 2.05e-05 | 2 | 85 | 2 | IPR013866 | |
| Domain | DUF3657 | 2.05e-05 | 2 | 85 | 2 | PF12394 | |
| Domain | DUF676_lipase-like | 2.05e-05 | 2 | 85 | 2 | IPR007751 | |
| Domain | Lipid_DES | 2.05e-05 | 2 | 85 | 2 | SM01269 | |
| Domain | MetalloPept_cat_dom | 3.39e-05 | 81 | 85 | 5 | IPR024079 | |
| Domain | - | 3.39e-05 | 81 | 85 | 5 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 8.45e-05 | 98 | 85 | 5 | PS00142 | |
| Domain | PI3K_Ras-bd_dom | 4.24e-04 | 7 | 85 | 2 | IPR000341 | |
| Domain | GPCR_kinase | 4.24e-04 | 7 | 85 | 2 | IPR000239 | |
| Domain | DAGAT | 4.24e-04 | 7 | 85 | 2 | PF03982 | |
| Domain | DAGAT | 4.24e-04 | 7 | 85 | 2 | IPR007130 | |
| Domain | PI3K_rbd | 4.24e-04 | 7 | 85 | 2 | PF00794 | |
| Domain | PI3K_RBD | 4.24e-04 | 7 | 85 | 2 | PS51546 | |
| Domain | PI3K_rbd | 4.24e-04 | 7 | 85 | 2 | SM00144 | |
| Domain | RGS | 5.36e-04 | 35 | 85 | 3 | PF00615 | |
| Domain | RGS | 5.36e-04 | 35 | 85 | 3 | SM00315 | |
| Domain | PI3K_C2_dom | 5.63e-04 | 8 | 85 | 2 | IPR002420 | |
| Domain | FA_desaturase_dom | 5.63e-04 | 8 | 85 | 2 | IPR005804 | |
| Domain | FA_desaturase | 5.63e-04 | 8 | 85 | 2 | PF00487 | |
| Domain | PI3K_C2 | 5.63e-04 | 8 | 85 | 2 | PF00792 | |
| Domain | PI3K_C2 | 5.63e-04 | 8 | 85 | 2 | PS51547 | |
| Domain | PI3K_C2 | 5.63e-04 | 8 | 85 | 2 | SM00142 | |
| Domain | RGS | 5.83e-04 | 36 | 85 | 3 | PS50132 | |
| Domain | PI3Ka | 7.22e-04 | 9 | 85 | 2 | PF00613 | |
| Domain | - | 7.22e-04 | 9 | 85 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 7.22e-04 | 9 | 85 | 2 | SM00145 | |
| Domain | Peptidase_M12B_N | 7.39e-04 | 39 | 85 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 7.39e-04 | 39 | 85 | 3 | PF01562 | |
| Domain | RGS | 7.39e-04 | 39 | 85 | 3 | IPR016137 | |
| Domain | DISINTEGRIN_1 | 7.96e-04 | 40 | 85 | 3 | PS00427 | |
| Domain | Reprolysin | 7.96e-04 | 40 | 85 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 7.96e-04 | 40 | 85 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.96e-04 | 40 | 85 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 7.96e-04 | 40 | 85 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 8.56e-04 | 41 | 85 | 3 | IPR001762 | |
| Domain | PIK_HELICAL | 9.00e-04 | 10 | 85 | 2 | PS51545 | |
| Domain | PI_Kinase | 9.00e-04 | 10 | 85 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 9.00e-04 | 10 | 85 | 2 | IPR001263 | |
| Domain | PI3/4_kinase_CS | 2.07e-03 | 15 | 85 | 2 | IPR018936 | |
| Domain | - | 2.36e-03 | 16 | 85 | 2 | 1.10.1070.11 | |
| Domain | Disintegrin_CS | 2.36e-03 | 16 | 85 | 2 | IPR018358 | |
| Domain | PI3Kc | 2.36e-03 | 16 | 85 | 2 | SM00146 | |
| Domain | NADP_OxRdtase_dom | 2.66e-03 | 17 | 85 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 2.66e-03 | 17 | 85 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.66e-03 | 17 | 85 | 2 | IPR001395 | |
| Domain | PI3/4_kinase_cat_dom | 2.99e-03 | 18 | 85 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.99e-03 | 18 | 85 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.99e-03 | 18 | 85 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.99e-03 | 18 | 85 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.99e-03 | 18 | 85 | 2 | PS00916 | |
| Domain | ADAM_CR | 2.99e-03 | 18 | 85 | 2 | PF08516 | |
| Domain | ConA-like_dom | 3.25e-03 | 219 | 85 | 5 | IPR013320 | |
| Domain | - | 3.69e-03 | 20 | 85 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 4.06e-03 | 21 | 85 | 2 | PF00200 | |
| Domain | DISIN | 4.06e-03 | 21 | 85 | 2 | SM00050 | |
| Domain | ARM-type_fold | 4.50e-03 | 339 | 85 | 6 | IPR016024 | |
| Domain | ABC_membrane | 5.29e-03 | 24 | 85 | 2 | PF00664 | |
| Domain | ACR | 6.67e-03 | 27 | 85 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 6.67e-03 | 27 | 85 | 2 | IPR006586 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 12051813 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23076141 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8638670 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33060647 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22589388 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8035170 | ||
| Pubmed | A novel GRK2/HDAC6 interaction modulates cell spreading and motility. | 5.90e-06 | 2 | 85 | 2 | 22193721 | |
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 5.90e-06 | 2 | 85 | 2 | 10198406 | |
| Pubmed | Identification and characterization of a sphingolipid delta 4-desaturase family. | 5.90e-06 | 2 | 85 | 2 | 11937514 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 5.90e-06 | 2 | 85 | 2 | 11762794 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21914808 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10754297 | ||
| Pubmed | Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma. | 1.77e-05 | 3 | 85 | 2 | 32108992 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22863590 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10085131 | ||
| Pubmed | Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts. | 1.77e-05 | 3 | 85 | 2 | 31299383 | |
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 1.77e-05 | 3 | 85 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 1.77e-05 | 3 | 85 | 2 | 31604529 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12071861 | ||
| Pubmed | Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. | 1.77e-05 | 3 | 85 | 2 | 16919859 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12130708 | ||
| Pubmed | Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. | 1.77e-05 | 3 | 85 | 2 | 12123834 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 24590062 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 39365156 | ||
| Pubmed | The molecular mechanisms mediating class II PI 3-kinase function in cell physiology. | 1.77e-05 | 3 | 85 | 2 | 33387369 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25779105 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12879023 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21784156 | ||
| Pubmed | Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. | 3.53e-05 | 4 | 85 | 2 | 8917529 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 8662816 | ||
| Pubmed | Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. | 3.53e-05 | 4 | 85 | 2 | 23734232 | |
| Pubmed | 3.95e-05 | 27 | 85 | 3 | 11156964 | ||
| Pubmed | Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. | 5.87e-05 | 5 | 85 | 2 | 9514948 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10338466 | ||
| Pubmed | Genetic mouse models of autism spectrum disorder present subtle heterogenous cardiac abnormalities. | 8.80e-05 | 6 | 85 | 2 | 35445787 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 27585885 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 33895473 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 9826657 | ||
| Pubmed | Molecular embryology of the lung: then, now, and in the future. | 8.80e-05 | 6 | 85 | 2 | 10330024 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 20074556 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 36451830 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 8672451 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 11517230 | ||
| Pubmed | 1.32e-04 | 105 | 85 | 4 | 9628581 | ||
| Pubmed | Genomic organization of the DGAT2/MOGAT gene family in cattle (Bos taurus) and other mammals. | 1.64e-04 | 8 | 85 | 2 | 14970677 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SEL1L CITED2 PTPRK RDH11 ANAPC1 GLI2 ZNF451 SOWAHC MGA TAP1 DEGS1 | 1.66e-04 | 1203 | 85 | 11 | 29180619 |
| Pubmed | 1.70e-04 | 210 | 85 | 5 | 16537572 | ||
| Pubmed | 1.70e-04 | 814 | 85 | 9 | 23251661 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEL1L HDAC6 PTPRK RDH11 AKR7L SPEG XPNPEP3 AKR7A3 GBE1 TAP1 DEGS1 ALPL | 2.09e-04 | 1451 | 85 | 12 | 30550785 |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 34873237 | ||
| Pubmed | Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. | 2.10e-04 | 9 | 85 | 2 | 10725236 | |
| Pubmed | 2.20e-04 | 497 | 85 | 7 | 23414517 | ||
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 2.62e-04 | 10 | 85 | 2 | 8636073 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 17846126 | ||
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 1869533 | ||
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 8798481 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 2.62e-04 | 10 | 85 | 2 | 9247029 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 28880886 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 21364421 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 21289201 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 16081599 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 22493482 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 9708406 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 39029571 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 10985305 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 3.20e-04 | 11 | 85 | 2 | 12584329 | |
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 9808187 | ||
| Pubmed | Essential role of Sox2 for the establishment and maintenance of the germ cell line. | 3.83e-04 | 12 | 85 | 2 | 23553930 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 14602571 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 16514418 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 28069795 | ||
| Pubmed | The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping. | 3.83e-04 | 12 | 85 | 2 | 10495887 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 10208934 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 12077252 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 9341793 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 12551992 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 23215766 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 9394803 | ||
| Pubmed | Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps. | 4.52e-04 | 13 | 85 | 2 | 16916379 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 18799682 | ||
| Pubmed | 4.97e-04 | 407 | 85 | 6 | 12693553 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 17157319 | ||
| Pubmed | Sonic hedgehog regulates branching morphogenesis in the mammalian lung. | 5.27e-04 | 14 | 85 | 2 | 9768363 | |
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 6.07e-04 | 15 | 85 | 2 | 18854243 | |
| Pubmed | 6.07e-04 | 15 | 85 | 2 | 35689447 | ||
| Pubmed | Efficient and fast targeted production of murine models based on ENU mutagenesis. | 6.07e-04 | 15 | 85 | 2 | 16075367 | |
| Pubmed | Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules. | 6.57e-04 | 69 | 85 | 3 | 21491542 | |
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 30111653 | ||
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 6.93e-04 | 16 | 85 | 2 | 16524887 | |
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 17567809 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 11289809 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 20019835 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 21029719 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 20818790 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.33e-04 | 608 | 85 | 7 | 36089195 | |
| Pubmed | 7.84e-04 | 17 | 85 | 2 | 28778798 | ||
| Pubmed | 7.84e-04 | 17 | 85 | 2 | 20813266 | ||
| Pubmed | 7.84e-04 | 17 | 85 | 2 | 23251686 | ||
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 7.84e-04 | 17 | 85 | 2 | 12960231 | |
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 7.84e-04 | 17 | 85 | 2 | 18453587 | |
| Cytoband | 1p36.13 | 1.58e-04 | 56 | 85 | 3 | 1p36.13 | |
| Cytoband | 8q22.2 | 8.36e-04 | 23 | 85 | 2 | 8q22.2 | |
| Cytoband | 22q12.1 | 1.62e-03 | 32 | 85 | 2 | 22q12.1 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 3.09e-04 | 8 | 61 | 2 | 1235 | |
| GeneFamily | Fatty acid desaturases | 3.09e-04 | 8 | 61 | 2 | 553 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 3.09e-04 | 8 | 61 | 2 | 831 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.72e-03 | 27 | 61 | 2 | 47 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN | 3.62e-06 | 199 | 84 | 7 | M6182 | |
| Coexpression | MEK_UP.V1_DN | 3.83e-05 | 194 | 84 | 6 | M2724 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_DN | 4.41e-05 | 199 | 84 | 6 | M8405 | |
| Coexpression | DESCARTES_ORGANOGENESIS_NOTOCHORD_CELLS | 4.46e-05 | 61 | 84 | 4 | MM3633 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP | 4.54e-05 | 200 | 84 | 6 | M7649 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_12H_BMDC_DN | 4.54e-05 | 200 | 84 | 6 | M3949 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.92e-08 | 193 | 85 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.63e-06 | 188 | 85 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 2.08e-06 | 196 | 85 | 6 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | 18|World / Age, Tissue, Lineage and Cell class | 2.27e-06 | 199 | 85 | 6 | ef043232ee028778b8ddb92aeed7584e2bf586d5 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-05 | 154 | 85 | 5 | 1c62290a2558fd6401b27de5a867d243b143b00a | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 158 | 85 | 5 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 158 | 85 | 5 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 164 | 85 | 5 | 95ce619ebf0cf5716b099fdc71267313f9dc9d32 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 164 | 85 | 5 | d0a7e8a7c530f8d7224b50f2abe3d3642fac142b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-05 | 166 | 85 | 5 | da10d0be6b616199d49dd922591c2901f9681583 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.76e-05 | 168 | 85 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-05 | 169 | 85 | 5 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.87e-05 | 170 | 85 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.73e-05 | 184 | 85 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 85 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.02e-05 | 188 | 85 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.26e-05 | 191 | 85 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.26e-05 | 191 | 85 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-05 | 192 | 85 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-05 | 192 | 85 | 5 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 194 | 85 | 5 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-05 | 194 | 85 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 194 | 85 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 195 | 85 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-05 | 195 | 85 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 195 | 85 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.78e-05 | 197 | 85 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 198 | 85 | 5 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-05 | 198 | 85 | 5 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 3.87e-05 | 198 | 85 | 5 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.96e-05 | 199 | 85 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 111 | 85 | 4 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 132 | 85 | 4 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 137 | 85 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 137 | 85 | 4 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 138 | 85 | 4 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 138 | 85 | 4 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 141 | 85 | 4 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 141 | 85 | 4 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 149 | 85 | 4 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.90e-04 | 149 | 85 | 4 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 151 | 85 | 4 | 7bc78aba6ab379d6eb00d4cf1843f532dfd4ce4e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 151 | 85 | 4 | f8ae05667a1db58a94be0f4e0b538bf80eb6b347 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.26e-04 | 156 | 85 | 4 | b0511ce81c446482339def3a0945fcbba6da35d0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 161 | 85 | 4 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 161 | 85 | 4 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 161 | 85 | 4 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.61e-04 | 162 | 85 | 4 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-04 | 163 | 85 | 4 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_OR1J1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-04 | 165 | 85 | 4 | 1f88f6939f88b80a0c98b4eef3684ba03c64ff7c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-04 | 166 | 85 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.93e-04 | 167 | 85 | 4 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.00e-04 | 168 | 85 | 4 | 907692c1f03d3c9889ba1bed5a4844e2c379db8e | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 3.00e-04 | 168 | 85 | 4 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.00e-04 | 168 | 85 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.14e-04 | 170 | 85 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | 13480e5f2de50425e42be0144b876e9aa4006a68 | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | d22cd09a43a14045bb1181189fe8accf78fdde3b | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | f9968d3735328a39157764343dd40f1ad8bf710d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-04 | 170 | 85 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 85 | 4 | 36fe66a8c0aecee7a19269be23210c0ed7abb155 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 172 | 85 | 4 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 172 | 85 | 4 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 6397b3fa72e2621a9a0f27f49446de2d3a30e420 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | de124fb7ded04664d4184bf12f1f201c0784f07c | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 174 | 85 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-04 | 174 | 85 | 4 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-04 | 176 | 85 | 4 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.58e-04 | 176 | 85 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-04 | 177 | 85 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-04 | 178 | 85 | 4 | c655b72ec22d45d2da69c2d8886a01831ce79558 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.74e-04 | 178 | 85 | 4 | 32cc4155267baf1b536a61310044e6502d09531f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-04 | 178 | 85 | 4 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-04 | 178 | 85 | 4 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-04 | 178 | 85 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.82e-04 | 179 | 85 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.82e-04 | 179 | 85 | 4 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.82e-04 | 179 | 85 | 4 | 381ac15d59f31bc613828bdcfbc9192b106b4d18 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.82e-04 | 179 | 85 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.82e-04 | 179 | 85 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.82e-04 | 179 | 85 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 180 | 85 | 4 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-04 | 180 | 85 | 4 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 180 | 85 | 4 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 180 | 85 | 4 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-04 | 180 | 85 | 4 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-04 | 180 | 85 | 4 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.98e-04 | 181 | 85 | 4 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.98e-04 | 181 | 85 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 3.98e-04 | 181 | 85 | 4 | 727344d7b2953568b7b3463398c7d56878cf2c2b | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 3.98e-04 | 181 | 85 | 4 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; PC3; HT_HG-U133A | 7.03e-07 | 198 | 84 | 8 | 4659_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 7.62e-06 | 194 | 84 | 7 | 7494_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 5964_UP | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 5810_DN | |
| Drug | iloprost | 1.04e-05 | 134 | 84 | 6 | CID005311181 | |
| Disease | glycochenodeoxycholate measurement | 1.42e-05 | 17 | 83 | 3 | EFO_0010490 | |
| Disease | Stage IV Skin Melanoma | 1.63e-04 | 7 | 83 | 2 | C1321872 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.07e-04 | 12 | 83 | 2 | C0023485 | |
| Disease | lobe size | 6.96e-04 | 14 | 83 | 2 | EFO_0007666 | |
| Disease | oleoylcarnitine measurement | 1.30e-03 | 19 | 83 | 2 | EFO_0021043 | |
| Disease | axial length measurement | 1.35e-03 | 77 | 83 | 3 | EFO_0005318 | |
| Disease | Prostatic Neoplasms | 1.76e-03 | 616 | 83 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.76e-03 | 616 | 83 | 7 | C0376358 | |
| Disease | influenza A (H1N1) | 1.92e-03 | 87 | 83 | 3 | EFO_1001488 | |
| Disease | transforming growth factor beta measurement | 2.62e-03 | 27 | 83 | 2 | EFO_0004818 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGVHTYELAMNHLGD | 66 | P43235 | |
| FSIAVAHHLGHNLGM | 326 | Q9UKF5 | |
| LDLMNGGDLHYHLSQ | 271 | P35626 | |
| GHMHHFALNPIFRHY | 556 | Q8NHU2 | |
| MYHHSQLQGAHGDAV | 271 | Q8NHP1 | |
| MYHHSQLQGAHGDAV | 271 | O95154 | |
| HSRPFMASIQYGGHH | 36 | P49863 | |
| QHMRRHHSGTDALYF | 1316 | Q8WXG9 | |
| VTLAHELGHNFGMNH | 346 | O43184 | |
| YMGHREIVEHLLDHG | 686 | Q9ULJ7 | |
| RMVGIGVEQLAYHHH | 481 | P51793 | |
| HGEQEHGLYSLHRMF | 16 | O75618 | |
| HMGQQLVGQYPIHFH | 546 | Q8WUJ3 | |
| IAHESGHNFGMIHDG | 431 | Q8TE57 | |
| LDLMNGGDLHYHLSQ | 271 | P25098 | |
| HAVGHHGAVTAAYHM | 56 | P43699 | |
| HMFHIDFGKFLGHAQ | 1046 | O75747 | |
| VYLAHTHDGARVAMH | 356 | Q15397 | |
| TGGEMNYGFHLAHHM | 1546 | Q9H1A4 | |
| NYGFHLAHHMALGLL | 1551 | Q9H1A4 | |
| MALYHNISGVGLFLH | 221 | O75106 | |
| SHNYIFGFHPHGIMA | 101 | Q96PD6 | |
| MTHRFGQNIPHYIHI | 261 | Q8NGH9 | |
| TGRHEHGLFNLYHAM | 1551 | Q4ZG55 | |
| HGLFNLYHAMDGASH | 1556 | Q4ZG55 | |
| LYHAMDGASHLHVLV | 1561 | Q4ZG55 | |
| GLHYDIHSLYGHSMA | 526 | Q2M2H8 | |
| LDQEGHIILHSMHRY | 186 | Q8IWI9 | |
| MHGTYDIGHVLLNFH | 306 | P78333 | |
| IAGQFYGHTHRDSIM | 286 | Q92484 | |
| AGTDGHVHLYSMLQA | 411 | Q96EX3 | |
| NPMGFAGLVSHLHYH | 1431 | Q8IY21 | |
| IMYHHLQPFLHGEES | 5231 | Q5CZC0 | |
| RGLHHHVNVMFDYFH | 146 | Q9P2D6 | |
| TGHMFHIDFGKFLGH | 1261 | O00443 | |
| MLEGHYHANVAYHNS | 376 | Q08493 | |
| GMYNCAHEMLHGHGD | 156 | P55160 | |
| HHLAASMSQEGYHQV | 1326 | P10070 | |
| FLDHVMYTIHMGCHG | 471 | Q13422 | |
| IDDFTPYHMLHGEVH | 631 | Q9ULW8 | |
| THHVHTYGLIMGGSN | 276 | Q9NVP1 | |
| HLQGLYGLSAVQTMH | 36 | Q8N2R0 | |
| PMAHLLHGVHEQNYV | 466 | P05186 | |
| LHGVHEQNYVPHVMA | 471 | P05186 | |
| IFYCKDQHHGGLLHM | 111 | Q9NPH6 | |
| MIHEVGHVLGLYHVF | 731 | Q9BXP8 | |
| GHMKYGVLHIHGLYT | 181 | Q9NWS6 | |
| GNLAGAYHKHLMELA | 201 | Q08462 | |
| FDGVTSMLYHHHGVG | 356 | Q04446 | |
| HNYLMGVHPHGLLTF | 96 | Q58HT5 | |
| GLHPISGHFIAEHYM | 221 | O15121 | |
| SGHFIAEHYMFLKGH | 226 | O15121 | |
| GLHPISGHFVAEHYM | 221 | Q6QHC5 | |
| SGHFVAEHYMFLKGH | 226 | Q6QHC5 | |
| YTGQLLHNLMGHADE | 456 | Q9NSI6 | |
| GSHYITLHMHRGVLV | 1201 | Q8IWT3 | |
| NGLHHQVPVMFDYFH | 146 | Q49AJ0 | |
| VYCGRYINGHMLQHH | 1151 | Q9UBN7 | |
| YINGHMLQHHGNSGH | 1156 | Q9UBN7 | |
| HVFMHLHPGTTYQFF | 556 | Q15262 | |
| VHGHSVNGEYLNVHM | 1686 | Q16363 | |
| VHADLSEFNMLYHGG | 321 | Q9BRS2 | |
| GFEMHIGVNHLGHFL | 141 | Q8TC12 | |
| VEALHLGTLMAAHGY | 76 | P49802 | |
| HFHCHLGYELQGAKM | 416 | Q9BYH1 | |
| GMLHFSTQYDLLHNH | 186 | Q9BSW7 | |
| GGHILAFYNLAQMHA | 516 | Q9UBV2 | |
| TYIFMHAGIEHLGLN | 216 | P58872 | |
| MGSRHFEGIYDHVGH | 1 | Q86VW1 | |
| IHYLASVFMGVTPHH | 36 | Q86VW1 | |
| GYAFGHMHDNNLEHL | 51 | Q8N5S1 | |
| DGIYNNTMGHVHSHL | 246 | Q03518 | |
| GYTALHLAAMHGHVE | 341 | Q53LP3 | |
| YILVHGTMPFDGHDH | 241 | Q9H093 | |
| NGMYGLHQDVHHFNS | 86 | P51688 | |
| DGVTESHHLHLYMPA | 96 | Q09428 | |
| MTHHHPTGYLGALAS | 161 | P54922 | |
| HAFNALMGEHIHYGA | 46 | Q99967 | |
| EVRTYFHEFGHVMHQ | 491 | Q9BYT8 | |
| IMAHVTEFHNGHRYF | 546 | Q9Y4E5 | |
| HTGMLQRHESYHTGD | 86 | Q96N58 | |
| HFYNIMHCGLLHIDQ | 1171 | Q6GYQ0 | |
| MVQLLQGLDYLHGHH | 3066 | Q15772 | |
| TLGDMKDHHGAVRHY | 361 | Q96HA7 | |
| EHGHHLQQYFNLFVM | 2171 | O00507 | |
| VLAFYDVTGGMSHLH | 401 | Q14142 | |
| LVHALAMHYAAGALF | 3631 | Q7Z7G8 | |
| HVGHYLGMDVHDTPD | 421 | Q9NQH7 | |
| IHMSALGLPGYHLHA | 66 | Q969M1 | |
| AHHIMGAGFGFHNIK | 261 | O60602 | |
| GFAMAGHENLSHGHT | 741 | P31629 | |
| FAHASGMQYHKLTEH | 816 | Q9NUA8 | |
| MYIAHHLLTLGHQFR | 546 | O43264 |